Dare Bioscience, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Dare Bioscience, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Dare Bioscience, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $160K, a 51.6% increase year-over-year.
  • Dare Bioscience, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $562K, a 69.7% increase year-over-year.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2023 was $400K, a 33.3% increase from 2022.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2022 was $300K, a 35.1% decline from 2021.
  • Dare Bioscience, Inc. annual Operating Lease, Payments for 2021 was $462K, a 0.22% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $400K +$100K +33.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $300K -$162K -35.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $462K +$1K +0.22% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $461K +$307K +199% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-30
2019 $154K Jan 1, 2019 Dec 31, 2019 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.